Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Radiomics: extracting more information from medical images using advanced feature analysis
Lambin, P., Rios-Velazquez, E., Leijenaar, R., Carvalho, S., van Stiphout, R. G. P. M., Granton, P., Zegers, C. M. L., Gillies, R., Boellard, R., Dekker, A., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.11.036 · Cited by 6,084 · cited 1×
“Recently, in addition to conventional parameters on FDG PET/CT and MRI used to stage disease, plan treatment and assess response there has been a growing interest in the extraction of quantitative features from medical images, denoted radiomics [6].”
BackgroundCollins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · BMJ · doi:10.1136/bmj.g7594 · Cited by 4,388
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777 · cited 6×
“Follow-up PET/CT (for all patients with the Siemens Biograph) was performed 3 months after treatment completion in order to assess therapeutic response with PERCIST: patients were classified as having complete metabolic response (CMR), partial metabolic response (PMR), stable metabolic disease (SMD), or progressive me…”
MethodInfluentialIntegrated genomic and molecular characterization of cervical cancer
The Cancer Genome Atlas Research Network (2017) · Nature · doi:10.1038/nature21386 · Cited by 1,479
Applications and limitations of radiomics
Yip, S. S. F., & Aerts, H. J. W. L. (2016) · Physics in Medicine and Biology · doi:10.1088/0031-9155/61/13/r150 · Cited by 1,210 · cited 5×
“To confirm the predictive value of the features identified in a cohort, validation on an external cohort of patients is considered the gold standard [8, 28].”
BackgroundInfluentialMachine Learning methods for Quantitative Radiomic Biomarkers
Parmar, C., Grossmann, P., Bussink, J., Lambin, P., & Aerts, H. J. W. L. (2015) · Scientific Reports · doi:10.1038/srep13087 · Cited by 1,019 · cited 1×
“A recent study investigated a large panel of machine-learning approaches for radiomics-based survival prediction, considering both features selection and classification methods [32].”
BackgroundCharacterization of PET/CT images using texture analysis: the past, the present… any future?
Hatt, M., Tixier, F., Pierce, L., Kinahan, P. E., Le Rest, C. C., & Visvikis, D. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3427-0 · Cited by 475 · cited 3×
“To confirm the predictive value of the features identified in a cohort, validation on an external cohort of patients is considered the gold standard [8, 29].”
BackgroundInfluentialSelf-citationLim, K., Small, W., Portelance, L., Creutzberg, C., Jürgenliemk-Schulz, I. M., Mundt, A., Mell, L. K., Mayr, N., Viswanathan, A., Jhingran, A., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.10.075 · Cited by 463 · cited 1×
“Consortium guidelines were applied to contour the clinical target volume (CTV), the planning target volume (PTV) and organs-at-risk [15].”
MethodHatt, M., Majdoub, M., Vallières, M., Tixier, F., Le Rest, C. C., Groheux, D., Hindié, E., Martineau, A., Pradier, O., Hustinx, R., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.144055 · Cited by 438 · cited 2×
“Other factors such as image acquisition parameters [29], tumor volume [30], gray-level discretization, and other preprocessing steps [8, 28] can influence radiomics findings.”
BackgroundSelf-citationSomatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer
Rios Velazquez, E., Parmar, C., Liu, Y., Coroller, T. P., Cruz, G., Stringfield, O., Ye, Z., Makrigiorgos, M., Fennessy, F., Mak, R. H., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0122 · Cited by 391 · cited 1×
“ological properties [7] and to provide prognostic informa-”
BackgroundGalavis, P. E., Hollensen, C., Jallow, N., Paliwal, B., & Jeraj, R. (2010) · Acta Oncologica · doi:10.3109/0284186x.2010.498437 · Cited by 344 · cited 1×
“Other factors such as image acquisition parameters [29], tumor volume [30], gray-level discretization, and other preprocessing steps [8, 28] can influence radiomics findings.”
BackgroundFalse Discovery Rates in PET and CT Studies with Texture Features: A Systematic Review
Chalkidou, A., O’Doherty, M. J., & Marsden, P. K. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124165 · Cited by 344 · cited 2×
“high risk of false-positive rate, as recently highlighted [8, 21, 28].”
BackgroundMethodGBM Volumetry using the 3D Slicer Medical Image Computing Platform
Egger, J., Kapur, T., Fedorov, A., Pieper, S., Miller, J. V., Veeraraghavan, H., Freisleben, B., Golby, A. J., Nimsky, C., & Kikinis, R. (2013) · Scientific Reports · doi:10.1038/srep01364 · Cited by 249 · cited 1×
“3D SlicerTM and the Growcut algorithm used are available for free and require minimal inputs from the user [26].”
MethodVolumetric CT-based segmentation of NSCLC using 3D-Slicer
Velazquez, E. R., Parmar, C., Jermoumi, M., Mak, R. H., van Baardwijk, A., Fennessy, F. M., Lewis, J. H., De Ruysscher, D., Kikinis, R., Lambin, P., et al. (2013) · Scientific Reports · doi:10.1038/srep03529 · Cited by 240 · cited 1×
“Each sequence was segmented independently because of anatomical changes between each sequence acquisition, using a previously validated semi-automatic approach exploiting 3D SlicerTM and the Growcut algorithm [18].”
MethodHatt, M., Lee, J. A., Schmidtlein, C. R., Naqa, I. E., Caldwell, C., De Bernardi, E., Lu, W., Das, S., Geets, X., Gregoire, V., et al. (2017) · Medical Physics · doi:10.1002/mp.12124 · Cited by 198
Self-citationRose, P. G., Java, J., Whitney, C. W., Stehman, F. B., Lanciano, R., Thomas, G. M., & DiSilvestro, P. A. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.7122 · Cited by 180 · cited 2×
“among patients with similar stage, which cannot be explained by differences in clinico-pathological features only [2].”
BackgroundHatt, M., Cheze le Rest, C., Descourt, P., Dekker, A., De Ruysscher, D., Oellers, M., Lambin, P., Pradier, O., & Visvikis, D. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.08.018 · Cited by 179 · cited 1×
“The metabolically active volumes on PET images were automatically delineated with the fuzzy locally adaptive Bayesian (FLAB) algorithm [16, 17].”
MethodSelf-citationThe Effect of Small Tumor Volumes on Studies of Intratumoral Heterogeneity of Tracer Uptake
Brooks, F. J., & Grigsby, P. W. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.116715 · Cited by 170 · cited 13×
“One texture from PET/CT (GLNUGLRLM-QE) and 3 from MRI (Inverse varianceGLCM-QF and EntropyGLCM-QF in ADC map and RLVARGLRLM-QL in CE-MRI) remained significantly correlated with LRC in univariate analysis after correction (p 0.00001, HR from 13 to 33), whereas none of the clinical factors reached statistical significan…”
BackgroundInfluentialRadiogenomic Analysis of Oncological Data: A Technical Survey
Incoronato, M., Aiello, M., Infante, T., Cavaliere, C., Grimaldi, A., Mirabelli, P., Monti, S., & Salvatore, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040805 · Cited by 150 · cited 2×
“molecular imaging approaches are required to further investigate these hypotheses [33, 34].”
BackgroundReuzé, S., Orlhac, F., Chargari, C., Nioche, C., Limkin, E., Riet, F., Escande, A., Haie-Meder, C., Dercle, L., Gouy, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17856 · Cited by 125 · cited 4×
“Another showed that (18)F–FDG PET/ CT features could predict local recurrence of LACC better than SUVmax [13].”
BackgroundMethodInfluentialImage biomarker standardisation initiative - feature definitions.Preprint
Zwanenburg, A., Leger, S., Vallières, M., & Löck, S. (2016) · arXiv (Cornell University) · Cited by 114
Antunes, J. T., Viswanath, S. E., Rusu, M., Valls, L., Hoimes, C. J., Avril, N. E., & Madabhushi, A. (2016) · Translational Oncology · doi:10.1016/j.tranon.2016.01.008 · Cited by 108 · cited 4×
“Our goal was to develop and validate such a PET/MRI signature with prognostic value for LRC and disease-free survival (DFS) in patients with LACC (stage IB1 to IVA) and to assess its incremental value with respect to the standard clinical and imaging features.”
InfluentialThe role of PET/CT in cervical cancer
Herrera, F. G., & Prior, J. O. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00034 · Cited by 96
Variability of clinical target volume delineation for definitive radiotherapy in cervix cancer
Eminowicz, G., & McCormack, M. M. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.10.007 · Cited by 75 · cited 1×
“Manual delineation is a straightforward solution, but is very time consuming and suffers from high inter- and intra-observer variability [26].”
BackgroundCollins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12376 · Cited by 58
Chung, H. H., Kang, S. Y., Ha, S., Kim, J., Park, N.-H., Song, Y. S., & Cheon, G. J. (2015) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2016.27.e15 · Cited by 56 · cited 1×
“in CC [9, 11, 13] and used to characterize CC lesions from diffusion-weighted MRI (DW-MRI) [12] or dynamic”
MethodHo, K., Fang, Y.-H. D., Chung, H., Yen, T., Ho, T., Chou, H., Hong, J., Huang, Y., Wang, C., & Lai, C. (2016) · Europe PMC (PubMed Central) · Cited by 51
Moore, K. N., Java, J., Slaughter, K. N., Rose, P. G., Lanciano, R. M., DiSilvestro, P., Thigpen, J. T., Lee, Y.-C., Tewari, K. S., Chino, J., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.08.317 · Cited by 49 · cited 1×
“allow choosing the appropriate treatment for patients with more aggressive CC [3].”
BackgroundTorheim, T., Groendahl, A. R., Andersen, E. K. F., Lyng, H., Malinen, E., Kvaal, K., & Futsæther, C. M. (2016) · Acta Oncologica · doi:10.1080/0284186x.2016.1189091 · Cited by 45 · cited 4×
“A third study showed that DCE-MRI 2 nd-order textures could predict treatment outcome [10].”
BackgroundInfluentialGuan, Y., Li, W., Jiang, Z., Chen, Y., Liu, S., He, J., Zhou, Z., & Ge, Y. (2016) · Academic Radiology · doi:10.1016/j.acra.2016.08.010 · Cited by 44 · cited 3×
“Radiomics features such as GLNUGLRLM on 18F-FDG PET and EntropyGLCM on ADC maps derived from DW-MRI were independent prognostic factors for disease outcome in LACC patients undergoing CRT, with significantly higher value than conventional factors.”
MethodYang, Z., & Liu, Z. (2019) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2019.12.017 · Cited by 21
Cited by
Simpson, G., Jin, W., Spieler, B., Portelance, L., Mellon, E., Kwon, D., Ford, J. C., & Dogan, N. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.807725 · Cited by 11
Metadata
- Authors
- Lucia, F., Visvikis, D., Desseroit, M.-C., Miranda, O., Malhaire, J.-P., Robin, P., Pradier, O., Hatt, M., & Schick, U.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2017-12-09
- Volume
- 45
- Issue
- 5
- Pages
- 768-786
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2772537473
- Cited by
- 245
- References
- 32
- FWCI
- 17.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.